Your shortcut for this week:
Read on for the foresight of the week and the full breakdown of what shaped healthcare AI 👇
Solutions and Launches
Google (US): Announced the Google Health app, Google Health Coach, and Fitbit Air, bringing wearable, app, and medical record data into a more unified health platform. [Link]
WHOOP (US): Announced upcoming in-app video consultations with licensed clinicians, alongside EHR syncing and new AI features for personalized coaching and proactive check-ins. [Link]
Hims & Hers (US): Launched Labs AI, an AI care agent that helps customers understand lab results by analysing biomarker history, health profiles, and trends over time. [Link]
Artera (US): Received FDA clearance for ArteraAI Breast, a digital pathology-based AI tool that stratifies distant metastasis risk in early-stage HR+/HER2-negative breast cancer. [Link]
Caris Life Sciences (US): Launched Caris MI Clarity, an AI-powered test that predicts early and late distant recurrence risk in postmenopausal patients with HR-positive/HER2-negative early-stage breast cancer. [Link]
Infinitus Systems (US): Released Lens, a healthcare conversation insights engine that analyzes every interaction to surface compliance gaps, sentiment signals, adherence barriers, and operational trends. [Link]
Fresenius & SAP (Germany): Invested in Avelios Medical to support an open, interoperable, AI-enabled digital healthcare ecosystem for hospitals in Germany and Europe. [Link]
Taimei Technology (China) & C&R Research (South Korea): Formed a strategic partnership to develop an AI-based clinical trial operations system, using AI agents to support data management, eCRF generation, and trial workflow automation. [Link]
Acer Medical (Taiwan): Expanded its AI ophthalmology footprint in Thailand through partnerships with New Eye Inc. and Upsynergy Taiwan, including VeriSee DR deployment for diabetic retinopathy screening in Phuket. [Link]
Governance, Policy, and Ethics
American College of Radiology (US): Approved a new practice parameter for imaging AI, outlining how radiology teams can select, test, govern, and monitor AI tools in real-world deployment. [Link]
FDA (US): Launched Elsa 4.0 and consolidated more than 40 FDA data sources into HALO, enabling staff to use internal AI for document generation, data analysis, search, and workflow support. [Link]
Pennsylvania Government (US): Filed a lawsuit against Character.AI, alleging its chatbots posed as licensed medical professionals and provided medical advice without proper licensure. [Link]
MHRA (UK): Published draft Medical Devices Regulations 2026 on the WTO portal, opening consultation on new pre-market requirements for medical devices and IVDs. [Link]
Canadian Privacy Regulators (Canada): Found OpenAI’s early ChatGPT training practices did not comply with Canadian privacy laws, raising concerns over personal data use, transparency, and safeguards. [Link]
Research and AI Advancements
SymptomAI (US): Evaluated conversational AI symptom assessment in 13,917 Fitbit app users, finding that dedicated AI symptom interviews outperformed user-guided conversations for differential diagnosis. [Link]
PhysicianBench (US): Introduced a Stanford benchmark for LLM agents in real EHR environments, where the best model completed only 46.3% of multi-step clinical workflow tasks. [Link]
MIT (US): Researchers demoed Human Operator, an AI system using Claude and wrist-worn electrical pads to directly control a user's hand movements (e.g., playing piano). [Link]
Partnerships & Adoption
Willis Knighton Health (US): Selected Commure as its enterprise ambient AI partner after a pilot where 88% of providers reported reduced charting time and cognitive burden. [Link]
Department of Health – Abu Dhabi (UAE) & ŌURA: Launched a research partnership using wearable data to study women’s health, preconception health, and perinatal care pathways. [Link]
UMC Utrecht (Netherlands): Received €65 million to lead AI4HEALTH, a national consortium focused on developing, validating, and scaling safe AI across healthcare practice. [Link]
Bets on the Next Health System
Investments:
Basata (US): Secured $21 million in Series A funding to scale AI agents that automate healthcare administration, including referrals, intake, scheduling, and follow-up. [Link]
Enzo Health (US): Secured $20 million in Series A funding to scale its AI platform for home health and post-acute care workflow automation. [Link]
Dandelion Health (US): Raised $14 million in Series A funding to expand its multimodal precision medicine platform for life sciences research. [Link]
XCaliber Health (US): Raised $6.5 million in seed funding to scale its agentic healthcare operating system for automating workflows such as scheduling, prescription refills, and EHR updates. [Link]
Modicus Prime (US): Raised $4.5 million to expand its AI compliance platform for audit-ready AI deployment in pharmaceutical environments. [Link]
M&A:
Roche (Switzerland): Agreed to acquire PathAI for $750 million upfront, expanding Roche’s AI-driven digital pathology and companion diagnostics capabilities. [Link]
HealthVerity (US): Entered an agreement to acquire Symphony Health, combining real-world clinical data and commercial analytics into an AI-ready healthcare data platform. [Link]
That’s a wrap for Edition #31 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.